Quick Research
Filters Clear All
Any Time
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 24,102 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
LPAR4-targeted dual-loaded liposome for synergistic lung cancer therapy (2025-06-22)
Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2025) IF: 4.7Products Cited: 5 mg/mL MTT solution -
Chemical coupling of an active/passive dual-targeting fusion protein ER(Fv)-HSA to DM1 improves its tumor-specificity and therapeutic efficacy against pancreatic cancer (2025-07-01)
Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2025) IF: 4.7Products Cited: MIA PaCa-2 Cells Line, PANC-1 Cells Line -
Enhancing Spinal Cord Injury Recovery with Functional Liposomal Nanomedicine: A Neuroprotective and Anti-Inflammatory Approach (2025-09-29)
Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2025) IF: 4.7 -
Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK/STAT signaling pathway (2025-06-03)
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2025) IF: 4.7Products Cited: RAW 264.7 Cell Complete Medium -
Protective effects of minocycline, a tetracycline antibiotic, on cytokine storm and oxidative stress in acute lung injury (2025-06-03)
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2025) IF: 4.7Products Cited: RAW 264.7 Cells Line -
Identification of cardiotoxic targets of doxorubicin via network toxicology and development of exosome-based delivery system for osteosarcoma therapy (2025-06-03)
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2025) IF: 4.7Products Cited: MG-63 Cells Line -
Tripartite motif containing 27 alleviated septic liver injury via the HSPA8/JNK pathway in mice (2025-06-11)
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2025) IF: 4.7Products Cited: DMEM (High glucose) Medium, AML12 Cells Line -
Pyrazolamide derivative T1 inhibits hepatocellular carcinoma cell proliferation through MAPK pathway modulation (2025-06-06)
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2025) IF: 4.7Products Cited: DMEM (High glucose) Medium, Enhanced Cell Counting Kit 8 (WST-8/CCK8) -
Gastrodin regulates H3K14la through the CDT2-KAT2A axis to treat Sepsis-induced myocardial dysfunction (2025-06-17)
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2025) IF: 4.7Products Cited: AC16 Cells Line -
IGF2BP2 regulates inflammation in ulcerative colitis through N6-methyladenosine-dependent modulation of CBR1 (2025-06-16)
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2025) IF: 4.7Products Cited: RPMI-1640 Medium, HT-29 Cells Line, HCT 116 Cells Line
